Antoine Yver

Director/Board Member at SANOFI

Net worth: 4 M $ as of 30/07/2024

66 year

99 connections

Health Technology

Consumer Services

Distribution Services

Profile

Antoine Yver's current jobs include being the Executive Vice President & Chairman-Development at Centessa Pharmaceuticals Plc, an Independent Director at Sanofi, and a Director at Spotlight Therapeutics, Inc. Previously, he worked as a Senior Director at Aventis SA from 1990 to 2005, as an Executive Director at Schering-Plough SAS from 2006 to 2009, as a Senior Director at Johnson & Johnson Medical SAS from 2005 to 2006, as the Head-Global Medicines Development at AstraZeneca PLC from 2015 to 2016, and as the EVP, Global Head-Oncology Research and Development at Daiichi Sankyo Co., Ltd.
from 2016 to 2021.
Dr. Yver obtained his undergraduate and doctorate degrees from Université Paris-Saclay.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CENTESSA PHARMACEUTICALS PLC 0.47%	29/04/2024	423,345 ( 0.47% )	4 M $	30/07/2024

Latest news about Antoine Yver

Press Release: Annual General Meeting of April 30, 2024	04-30	GL
Sanofi Announces Board and Committee Appointments	04-30	CI
Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-3 Study Evaluating SerpinPC for the Treatment of Hemophilia B with Inhibitors	31/10/23	GL
Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-3 Study Evaluating SerpinPC for the Treatment of Hemophilia B with Inhibitors	31/10/23	AQ
Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-2 Study Evaluating SerpinPC for the Treatment of Hemophilia B without Inhibitors	10/07/23	GL

Antoine Yver active positions

Companies	Position	Start
CENTESSA PHARMACEUTICALS PLC	Corporate Officer/Principal	06/03/2022
SANOFI	Director/Board Member	02/05/2022
Spotlight Therapeutics, Inc. Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA.	Director/Board Member	03/07/2022

All active positions of Antoine Yver

Former positions of Antoine Yver

Companies	Position	End
DAIICHI SANKYO CO., LTD.	Corporate Officer/Principal	31/03/2021
ASTRAZENECA PLC	Corporate Officer/Principal	31/12/2015
Schering-Plough SAS Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Founded in 1900, Schering-Plough SAS is a French pharmaceutical company that manufactures pharmaceutical products. Part of Merck & Co., Inc., the company is based in Puteaux, France.	Corporate Officer/Principal	31/12/2008
Johnson & Johnson Medical SAS Johnson & Johnson Medical SAS Medical DistributorsDistribution Services Part of Johnson & Johnson, Johnson & Johnson Medical SAS is a French company that wholesales pharmaceutical products. The company is based in Issy-les-Moulineaux, France. The CEO of the company is Myriam Martinez Climent.	Corporate Officer/Principal	31/12/2005
Aventis SA Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France.	Corporate Officer/Principal	31/12/2004

See the detail of Antoine Yver's experience

Training of Antoine Yver

Université Paris-Saclay

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Antoine Yver's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	4
ASTRAZENECA PLC	Health Technology
DAIICHI SANKYO CO., LTD.	Health Technology
CENTESSA PHARMACEUTICALS PLC	Health Technology
SANOFI	Health Technology

Private companies	4
Spotlight Therapeutics, Inc. Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA.	Health Technology
Aventis SA Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France.	Health Technology
Johnson & Johnson Medical SAS Johnson & Johnson Medical SAS Medical DistributorsDistribution Services Part of Johnson & Johnson, Johnson & Johnson Medical SAS is a French company that wholesales pharmaceutical products. The company is based in Issy-les-Moulineaux, France. The CEO of the company is Myriam Martinez Climent.	Distribution Services
Schering-Plough SAS Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Founded in 1900, Schering-Plough SAS is a French pharmaceutical company that manufactures pharmaceutical products. Part of Merck & Co., Inc., the company is based in Puteaux, France.	Health Technology